Juxtapid Maker Gets FDA Warning Letter Over Misleading Statements
The makers of Juxtapid received an FDA warning letter after television appearances the agency says included misleading statements about the drug.
The makers of Juxtapid received an FDA warning letter after television appearances the agency says included misleading statements about the drug.